Evogene and Shanghai Lishan Biopharmaceuticals (Lishan Biotech) have announced that Biomica, Evogene’s subsidiary, and Lishan Biotech entered into an exclusive worldwide licensing agreement for BMC128 (designated as LS-LBP-002 by Lishan Biotech).
After Cytiva, a Danaher company, unveiled Fibro dT platform for enhanced mRNA purification, European Pharmaceutical Manufacturer spoke to Emmanuel Abate, President of Genomic Medicine and head of sustainability at Cytiva to gain more information.
European Pharmaceutical Manufacturer spoke to Gavin Murdoch, SVP Commercial Strategy, Abzena at CPHI about the AbZelectPRO cell line development platform.
At CPHI Frankfurt, we sat down with Peter Bains, MD & CEO of Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs) and the broader evolution of integrated development in biologics.
IDA Ireland has published a comprehensive new whitepaper, "The Future of Biopharma in Ireland: Unlocking Growth Through Innovation, Investment, and Collaboration."
Leonardo Magneschi, vice president of research & technology development, Ingenza looks at building robust and reliable paths for biologics manufacturing.
In a drug development landscape defined by shifting policies, geopolitical uncertainty, and increasing competitive pressure, a new collaborative strategy platform, Nmblr, has launched to empower teams to reach peak sales faster and with confidence.
Trelleborg Medical Solutions announces the grand opening of its expanded manufacturing facility and BioPharma Center of Excellence in Northborough, Massachusetts, driving its strategy for growth in the biopharmaceutical industry.
